Impact of neutropenia on the outcomes of critically ill patients with cancer: A matched case-control study

Annals of Oncology

Volumn 22, Issue 9, 2011, Pages 2094-2100

  Souza Dantas, V C ^a   Salluh, J I F ^a   Soares, M ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Cancer; Case control study; Intensive care unit; Neutropenia; Outcome

Indexed keywords

ANTIBIOTIC AGENT; HYPERTENSIVE FACTOR;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CASE CONTROL STUDY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NEUTROPENIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEPSIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRAZIL; CASE-CONTROL STUDIES; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 79959924977     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq711     Document Type: Article

References (38)

1. Taccone FS, Artigas AA, Sprung CL et al. Characteristics and outcomes of cancer patients in European ICUs. Crit Care 2009; 13: R15.
2. Metnitz PG, Moreno RP, Almeida E et al. SAPS 3-from evaluation of the patient to evaluation of the intensive care unit. Intensive Care Med 2005; 31: 1336-1344.
3. Soares M, Caruso P, Silva E et al. Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med 2010; 38: 9-15.
4. Staudinger T, Stoiser B, Mullner M et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000; 28: 1322-1328.
5. Azoulay E, Alberti C, Bornstain C et al. Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 2001; 29: 519-525.
6. Kress JP, Christenson J, Pohlman AS et al. Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 1999; 160: 1957-1961.
7. Soares M, Salluh JI, Torres VB et al. Short- and long-term outcomes of critically ill patients with cancer and prolonged ICU length of stay. Chest 2008; 134: 520-526.
8. Azoulay E, Moreau D, Aberti C et al. Predictors of short-term mortality in critically ill patients with solid malignancies. Intensive Care Med 2000; 26: 1817-1823.
9. Blot F, Guiguet M, Nitenberg G et al. Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur J Cancer 1997; 33: 1031-1037.
10. Vandijck DM, Benoit DD, Depuydt PO et al. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med 2008; 34: 847-855.
11. Darmon M, Azoulay E, Alberti C et al. Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients. Intensive Care Med 2002; 28: 1775-1780.
12. Cornet AD, Issa AI, Van de Loosdrecht AA et al. Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care. Eur J Haematol 2005; 72: 511-516.
13. Hampshire PA, Welch CA, McCrossan LA et al. Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 2009; 13: R137.
14. Vallot F, Paesmans M, Berghmans T et al. Leucopenia is an independent predictor in cancer patients requiring invasive mechanical ventilation: a prognostic factor analysis in a series of 168 patients. Supp Care Cancer 2003; 11: 236-241.
15. Benoit DD, Wandewoude KH, Decruyenaere JM et al. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med 2003; 31: 104-112.
16. Maschmeyer G, Bertschat FL, Moesta KT et al. Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year period. Eur J Cancer 2003; 39: 783-792.
17. Lloyd-Thomas AR, Wright I, Lister TA et al. Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy. BMJ 1988; 296: 1025-1029.
18. Blot F, Cordonnier C, Buzin A et al. Severity of illness scores: Are they useful in febrile neutropenic adult patients in hematology wards? A prospective multicenter study. Crit Care Med 2001; 29: 2125-2131.
19. Guiguet M, Blot F, Escudier B et al. Severity-of-illness scores for neutropenic cancer patients in an intensive care unit: Which is the best predictor? Do multiple assessment times improve the predictive value. Crit Care Med 1998; 26: 488-493.
20. Soares M, Fontes F, Dantas J et al. Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study. Crit Care 2004; 8: R194-R203.
21. Hughes WT, Armstrong D, Bodey GP et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-751.
22. Le Gall J-R, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-2963.
23. Vincent JL, Moreno R, Takala J et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-710.
24. Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
25. Piccirillo JF. Adult Comorbidity Evaluation-27. Comorbidity data collection form. 2001, http://oto.wustl.edu/clinepi/downloads.html (5 April 2010, date last accessed).
26. Garner JS, Jarvis WR, Emori TG et al. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128-140.
27. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
28. Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd edition. New York, NY: Wiley-Interscience 2000.
29. Hanley JA, McNeil BJ. The meaning and use of the area under receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
30. Azoulay E, Fieux F, Moreau D et al. Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med 2003; 167: 1329-1333.
31. Khorana AA, Francis CW, Culakova E et al. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 2006; 24: 484-490.
32. Péne F, Aubron C, Azoulay E et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 2006; 24: 643-649.
33. Lyman GH, Kuderer NM, Djulbecovic B. Prophylactic granulocyte colonystimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis. Am J Med 2002; 112: 406-411.
34. Lilienfeld DE, Stolley PD. Foundations of Epidemiology, 3rd edition. New York, NY: Oxford University Press 1994.
35. Soares M, Carvalho MS, Salluh JIF et al. Effect of age on survival of critically ill patients with cancer. Crit Care Med 2006; 34: 715-721.
36. Péne F, Percheron S, Lemiale V et al. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med 2008; 36: 690-696.
37. Soares M, Azoulay E. Critical care management of lung cancer patients to prolong life without prolonging dying. Intensive Care Med 2009; 35: 2012-2014.
38. Azoulay E, Darmon M, Delclaux C et al. Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med 2002; 30: 781-786.